HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

884.453

+0.3360.04%

Number of Gainers:7

Number of Losers:9

Number of Flat:1

PE:- -

High:897.274

Open:884.196

Low:862.733

Close:884.117

Volume:235.66M

Turnover:1.84B

Market Cap:598.32B

Float Cap:494.40B

Loading ...

Shandong Xinhua Pharmaceutical's Board Secretary Cao Changqiu Plans to Reduce Holdings by No More Than 83,300 Shares

Sinopharm Group Stock Rallies 2.2% in Hong Kong

JD Health Showcases Smart Elderly Care Vision at Beijing International Aging Industry Expo

CanSino Biologics Receives Government Income-Related Subsidy; Hong Kong Shares Down 5%

MT Newswires Live

Ascletis Pharma-B Repurchases 200,000 Shares for Approximately HK$1.3703 Million on October 12

AI Plus Human Doctors Plus Ecosystem Model Fully Implemented as PA Gooddoctor Named a Typical Case in Frost & Sullivan Global AI Healthcare Blue Book

Baiyunshan's Subsidiary Receives Clinical Trial Approval for Shujin Jianyao Pill

Fund Performance Rankings for the First Three Quarters: Semiconductors Dominate, Crude Oil Follows, Pharmaceuticals Rebound

Baiyunshan's Tianxin Pharmaceutical Secures NMPA Drug Registration Certificate for Irbesartan Hydrochlorothiazide Tablets

Shandong Xinhua Pharmaceutical (00719): Liu Weimin Proposed as Candidate for Executive Director Appointment

Shandong Xinhua Pharmaceutical Co - Board Proposes Liu Weimin as Executive Director

THOMSON REUTERS

Sino Biopharmaceutical Stock Falls 1.4% in Hong Kong

JD Health International Stock Rises 2.0% in Hong Kong

Hong Kong Regulators Issue Joint Statement on Audit Opinions; Nasdaq Slides 1.25%

SIHUAN PHARM Makes Strategic Investment in Hanteng Biotech to Complete Regenerative Medical Aesthetics Industry Chain

Sihuan Pharma - Unit Completes Strategic Equity Investment in Canton Biologics

THOMSON REUTERS

Is Ping An Healthcare and Technology (SEHK:1833) A Bargain As Valuation Signals Diverge?

Simply Wall St.

GenFleet-B (02595) Spends HK$3.83 Million to Buy Back 135,000 Shares on October 8

CSPC Pharma Presents Data from Cervical Cancer Study at Gynecologic Cancer Society Meeting

MT Newswires Live

Sino Biopharma Unit Completes Patient Enrollment for Pulmonary Disease Drug Trial

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketd.com/stock/BK1515/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":884.453,"timestamp":1791878906339,"preClose":884.1166,"halted":0,"volume":235657981,"delay":0,"changeRate":0.000381,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":0.336426,"latestTime":"10-13 16:00:00","open":884.1956,"high":897.2744,"low":862.7329,"amount":1835180903,"amplitude":0.039069,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791941400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791855000000,1791864000000],[1791867600000,1791878400000]],"pbRate":1.337327,"peRate":17.330526,"turnoverRate":0.002937,"increases":7,"decrements":10,"flats":0,"marketCap":598323136768,"floatMarketCap":494396369792},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":897.2744,"amplitude":0.039069,"preClose":884.1166,"low":862.7329,"pbRate":"1.337327","latestPrice":884.453,"volume":235657981,"delay":0,"open":884.1956,"prevYearClose":1190.107,"prevWeekClose":890.643,"prevMonthClose":925.469,"prevQuarterClose":925.469,"fiveDayClose":924.393,"twentyDayClose":888.076,"sixtyDayClose":922.819,"secType":"PLATE","market":"HK","turnoverRate":0.002937,"peRate":17.330526,"marketCap":598323136768,"floatMarketCap":494396369792,"timestamp":1791878906339,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":7,"down":9,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1150684250","title":"Shandong Xinhua Pharmaceutical's Board Secretary Cao Changqiu Plans to Reduce Holdings by No More Than 83,300 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1150684250","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150684250?lang=en_us&edition=fundamental","pubTime":"2026-10-13 17:30","pubTimestamp":1791883829,"startTime":"0","endTime":"0","summary":"Shandong Xinhua Pharmaceutical Co., Ltd. (00719) announced that the company recently received a \"Notice of Share Reduction Plan\" from Mr. Cao Changqiu, the company's Board Secretary. He plans to...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1515","00719"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675661334","title":"Sinopharm Group Stock Rallies 2.2% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2675661334","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675661334?lang=en_us&edition=fundamental","pubTime":"2026-10-13 16:30","pubTimestamp":1791880200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. advanced 2.2% to 15.13 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.3% to 24345.22.Sinopharm Group Co. Ltd. closed 32% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 1.4%.Trading volume totaled 10.2 million shares, compared to the 50-day average of 4.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0012","BK0239","BK1197","BK0060","BK1593","SHTDY","BK0096","91335","01099","BK0028","BK1191","BK0196","BK0175","BK4175","02196","BK0187","LU1115378108.SGD","LU0640798160.USD","BK1515","BK1500","BK0183","600196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100249322","title":"JD Health Showcases Smart Elderly Care Vision at Beijing International Aging Industry Expo","url":"https://stock-news.laohu8.com/highlight/detail?id=1100249322","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100249322?lang=en_us&edition=fundamental","pubTime":"2026-10-13 14:38","pubTimestamp":1791873500,"startTime":"0","endTime":"0","summary":"According to Zhi Tong Finance APP, the 12th Beijing International Aging Industry Expo was recently held in Beijing. JD.com appeared at the expo, presenting its one-stop elderly care service...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["86618","BK1589","BK1591","LU0051755006.USD","SGXZ86797644.SGD","LU0456827905.SGD","BK1142","BK1583","BK1615","BK1247","SGXZ62798434.SGD","06618","BK1571","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675333086","title":"CanSino Biologics Receives Government Income-Related Subsidy; Hong Kong Shares Down 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675333086","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675333086?lang=en_us&edition=fundamental","pubTime":"2026-10-13 14:17","pubTimestamp":1791872239,"startTime":"0","endTime":"0","summary":"CanSino Biologics  received a government income-related subsidy of 2.9 million yuan, according to a Tuesday filing with the Shanghai bourse.The subsidy amount is equivalent to 10% of the company's audited net profit for its most recent fiscal year, the filing said.The drug company's Hong Kong shares fell 5% while its Shanghai-traded shares slipped 3 on Tuesday afternoon.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","BK1161","BK0239","BK1574","688185","06185","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168718640","title":"Ascletis Pharma-B Repurchases 200,000 Shares for Approximately HK$1.3703 Million on October 12","url":"https://stock-news.laohu8.com/highlight/detail?id=1168718640","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168718640?lang=en_us&edition=fundamental","pubTime":"2026-10-12 18:58","pubTimestamp":1791802700,"startTime":"0","endTime":"0","summary":"Ascletis Pharma-B (01672) announced that on October 12, 2026, it spent approximately HK$1.3703 million to repurchase 200,000 shares.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","BK1574","BK1191","01477","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177489977","title":"AI Plus Human Doctors Plus Ecosystem Model Fully Implemented as PA Gooddoctor Named a Typical Case in Frost & Sullivan Global AI Healthcare Blue Book","url":"https://stock-news.laohu8.com/highlight/detail?id=1177489977","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177489977?lang=en_us&edition=fundamental","pubTime":"2026-10-12 18:30","pubTimestamp":1791801037,"startTime":"0","endTime":"0","summary":"Recently, the globally renowned consulting firm Frost & Sullivan officially released the 2026 Global AI Healthcare Industry Development Blue Book, which systematically reviews the technological...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","BK1615","BK1617","VTHR","QTOC","BK1247","AIPO","CHAT","ARTY","159891","BK1142","BK1219","BK1515","01833","BK1571"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188389410","title":"Baiyunshan's Subsidiary Receives Clinical Trial Approval for Shujin Jianyao Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=1188389410","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188389410?lang=en_us&edition=fundamental","pubTime":"2026-10-12 16:18","pubTimestamp":1791793102,"startTime":"0","endTime":"0","summary":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SH) has announced that its subsidiary, Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. (referred to as \"Chenliji...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","IBBJ","00874","600332","PSYK","BK1515","BK0028","BK0012","IBBQ","BK1521","BK1606","BK0183","BK0097","BK0196","BK0070","BK0239","BK0175","BMED","BK1197","BK1191","MDTX","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178015402","title":"Fund Performance Rankings for the First Three Quarters: Semiconductors Dominate, Crude Oil Follows, Pharmaceuticals Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1178015402","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178015402?lang=en_us&edition=fundamental","pubTime":"2026-10-10 16:41","pubTimestamp":1791621699,"startTime":"0","endTime":"0","summary":"During the first three quarters of 2026, the A-share market experienced a structural rally driven by the dual forces of domestic semiconductor substitution and the AI computing power wave, leading...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159582","CLmain","SMHX","USE","USO","DBO","SMHU","FWD","SOXX","FAAR","FTXN","OILU","BK4588","WTIU","SOXY","BZmain","SCO","XSD","DRLL","SOXS","BK1515","BK4585","DRIP","PXJ","BK1161","VGT","09939","IEO","NBDS","DIG","MCLmain","USL","VDE","MQQQ","BK4570","CHPY","CWC","GUSH","XES","UGA","USD","SOXQ","BK4535","DWT","IXC","OILT","TECY","PSI","USOI","DBC","UCO","OILK","CHPS","SOXL","SSG","DBE","PXE","SMH","OIH","DDG","XOP","BK1574","FTXL","TEKX","FLBR","159938","FBZ","ERX","DUG","BNO","QMmain","EIS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188530342","title":"Baiyunshan's Tianxin Pharmaceutical Secures NMPA Drug Registration Certificate for Irbesartan Hydrochlorothiazide Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1188530342","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188530342?lang=en_us&edition=fundamental","pubTime":"2026-10-09 18:00","pubTimestamp":1791540015,"startTime":"0","endTime":"0","summary":"Baiyunshan (ASX: 00874) has announced that its controlling subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (\"Tianxin Pharmaceutical\"), recently received a Drug Registration...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0175","BK1515","BK0196","BK0097","BK0012","BK1606","BK0028","00874","BK0070","BK1191","BK0183","BK0096","BK0239","BK1197","600332","01477","BK1521","BK1574","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161581394","title":"Shandong Xinhua Pharmaceutical (00719): Liu Weimin Proposed as Candidate for Executive Director Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=1161581394","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161581394?lang=en_us&edition=fundamental","pubTime":"2026-10-09 17:40","pubTimestamp":1791538813,"startTime":"0","endTime":"0","summary":"Shandong Xinhua Pharmaceutical (00719) has issued an announcement stating that the Board of Directors has resolved to propose Mr. Liu Weimin (Mr. Liu) as a candidate for appointment as an executive...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00719","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674309468","title":"Shandong Xinhua Pharmaceutical Co - Board Proposes Liu Weimin as Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2674309468","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674309468?lang=en_us&edition=fundamental","pubTime":"2026-10-09 17:37","pubTimestamp":1791538651,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nFWN45V12W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK0164","BK1515","00719","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674328258","title":"Sino Biopharmaceutical Stock Falls 1.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2674328258","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674328258?lang=en_us&edition=fundamental","pubTime":"2026-10-09 16:33","pubTimestamp":1791534780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.4% to 5.41 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.8% to 24211.35.This was the stock's third consecutive day of losses.Sino Biopharmaceutical Ltd. closed 33% short of its 52-week high of HK$8.08, which the company reached Oct. 10.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 2.2% and Amgen Inc. remained unchanged.Trading volume totaled 72.7 million shares, compared to the 50-day average of 80.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","HK0000165453.HKD","BK1521","IBBQ","BK1191","IE0009355771.USD","LU1023059063.AUD","BK4566","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","LU2242646821.SGD","PBE","IE00BJT1NW94.SGD","IBB","LU1061106388.HKD","SG9999001440.SGD","IE00BJJMRZ35.SGD","BK4533","LU0109394709.USD","BK4585","BK4139","LU1571399168.USD","BK4534","LU2089984988.USD","LU1057294990.SGD","LU0868494617.USD","LU0320765992.SGD","LU0058720904.USD","BK4581","BK4599","LU0889565916.HKD","IE00BZ08YT58.USD","IE00B2B36J28.USD","LU1983299246.USD","LU2112291526.USD","LU2242652126.USD","BK1515","LU0122379950.USD","IE00BFTCPJ56.SGD","BK1589","PJP","IE00B4R5TH58.HKD","BK4588","LU0289739699.SGD","TBXU","BIB","BBH","AMGN","01177","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674303832","title":"JD Health International Stock Rises 2.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2674303832","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674303832?lang=en_us&edition=fundamental","pubTime":"2026-10-09 16:33","pubTimestamp":1791534780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. rose 2.0% to 36.08 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.8% to 24211.35.This was the stock's fifth consecutive day of gains.JD Health International Inc. closed 50% below its 52-week high of HK$71.70, which the company achieved Jan. 15.Trading volume totaled 5.0 million shares, compared to the 50-day average of 8.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1247","BK1589","86618","BK1142","06618","BK1615","BK1571","SGXZ62798434.SGD","SGXZ86797644.SGD","BK1583","LU0456827905.SGD","BK1515","LU0051755006.USD","BK1591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114675251","title":"Hong Kong Regulators Issue Joint Statement on Audit Opinions; Nasdaq Slides 1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114675251","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114675251?lang=en_us&edition=fundamental","pubTime":"2026-10-09 08:02","pubTimestamp":1791504126,"startTime":"0","endTime":"0","summary":"Hong Kong's Securities and Futures Commission, the Accounting and Financial Reporting Council, and the Stock Exchange of Hong Kong have issued a joint statement addressing growing regulatory concerns...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422952.EUR","00883","LU2148510915.USD","01748","LU0531971595.HKD","PONY","LU0516422440.USD","SBHMY","LU0516422366.SGD","SG9999001093.SGD","BK1593","LU1242518931.SGD","LU0516423174.USD","LU1242518857.USD","02026","IE00BZ08YS42.EUR","BK1213","600938","IXIC","06887","LU0149721374.USD","BK1114","00460","BK1181","LU0163747925.USD","06288","LU0871576103.HKD","LU1064131003.USD","LU0164880469.USD","LU0039217434.USD","LU0516423091.SGD","BK1594","LU1481107354.HKD","BK1528","02720","LU0164865239.USD","BK1511","FRCOY","BK1589","BK1109","LU0979878070.USD","06055","BK1191","BK1610","HK0000165453.HKD","80883","BK1522","BK1515","BK1580","01177","BK1600","LU1064130708.USD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","00189","BK1521","BK1129","BK1238","BK1502","LU0228367735.SGD","BK1103"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177960521","title":"SIHUAN PHARM Makes Strategic Investment in Hanteng Biotech to Complete Regenerative Medical Aesthetics Industry Chain","url":"https://stock-news.laohu8.com/highlight/detail?id=1177960521","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177960521?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:56","pubTimestamp":1791464176,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) has announced that its subsidiary Meiyan Space Biotechnology (Jilin) Co., Ltd. (Meiyan Space) has completed a strategic equity investment in Guangzhou Hanteng Biotechnology Co.,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1515","BK1191","BK1593","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673635077","title":"Sihuan Pharma - Unit Completes Strategic Equity Investment in Canton Biologics","url":"https://stock-news.laohu8.com/highlight/detail?id=2673635077","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673635077?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:42","pubTimestamp":1791463373,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nFWN45U1S7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1600","BK1593","00460","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673003676","title":"Is Ping An Healthcare and Technology (SEHK:1833) A Bargain As Valuation Signals Diverge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673003676","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673003676?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:32","pubTimestamp":1791462764,"startTime":"0","endTime":"0","summary":"Ping An Healthcare and Technology (SEHK:1833) has drawn fresh attention after recent share performance, with the stock down 8% over the past month and about 21% over the past 3 months.\nAt a share price of HK$5.96, Ping An Healthcare and Technology has not only slipped over the past month, it has also seen its 1-year total shareholder return decline 66.12%, which signals fading momentum as investors reassess both growth prospects and risk.\nCompare Ping An Healthcare and Technology's slide with...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/5021000-choice2-card/1789013271957","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/5021000-choice2-card/1789013271957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/is-ping-an-healthcare-and-technology-sehk1833-a-bargain-as-v","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/is-ping-an-healthcare-and-technology-sehk1833-a-bargain-as-v","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1615","XBI","LU0128526141.USD","BK1617","LU0029874061.USD","BK1515","BK4137","BK1247","01833","BK4581","BK1219","BK1571","DCF","BK4585","HCSG","BK1142","XLV","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186524088","title":"GenFleet-B (02595) Spends HK$3.83 Million to Buy Back 135,000 Shares on October 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1186524088","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186524088?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:48","pubTimestamp":1791460092,"startTime":"0","endTime":"0","summary":"GenFleet-B (02595) announced that on October 8, 2026, it spent HK$3.8307 million to repurchase 135,000 shares.The company disclosed the share repurchase in a filing.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","02595","BK1574","BK1161","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673907195","title":"CSPC Pharma Presents Data from Cervical Cancer Study at Gynecologic Cancer Society Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2673907195","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673907195?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:30","pubTimestamp":1791459000,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  presented data from a phase I clinical study of SYS6002 as a rapid oral presentation at the 2026 Annual Global Meeting of the International Gynecologic Cancer Society.The trial testing the drug as monotherapy for the treatment of advanced cervical cancer found it to have a manageable safety profile and preliminary efficacy, a Thursday bourse filing showed.The drug is currently being studied for the treatment of advanced cervical cancer previously treated with immunotherapy in a phase III trial.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KURE","IE00BZ08YR35.GBP","LU1993786604.SGD","LU1807302812.USD","SG9999004220.SGD","IE00B031HY20.USD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","LU0314109678.HKD","IE00BZ08YT58.USD","LU0072913022.USD","LU0315179316.USD","IE0008369823.USD","LU1951186391.HKD","IE0008368742.USD","01093","BK1521","LU1226287529.USD","LU0501845795.SGD","LU1328277881.USD","LU1152091754.HKD","BK1191","IE00B5MMRT66.SGD","LU1226287875.USD","LU1960683339.HKD","LU2039709279.SGD","LU1226288170.HKD","LU1226288253.USD","LU1813983027.USD","BK1515","LU0880133367.SGD","LU0326950275.SGD","LU1008478684.HKD","LU1152091168.USD","LU0067412154.USD","HK0000165453.HKD","LU1226287792.SGD","LU0140636845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673165079","title":"Sino Biopharma Unit Completes Patient Enrollment for Pulmonary Disease Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2673165079","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673165079?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:04","pubTimestamp":1791457490,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical  said the enrollment of all subjects for a phase III clinical trial of TQC3721 inhalation suspension has been completed.The drug was developed by unit Chia Tai Tianqing Pharmaceutical Group for the maintenance treatment of chronic obstructive pulmonary disease, a Thursday bourse filing showed.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ08YS42.EUR","HK0000165453.HKD","IE00BZ08YT58.USD","BK1191","01177","IE00BZ08YR35.GBP","BK1515","BK1589","BK1521"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":105,"code":"91000000","status":"200"}]}}